CDC-RFA-GH21-2156: Maintaining and Strengthening Institutional Capacity of Maputo City Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - CGH notices from 2021.
Centers for Disease Control - CGH offered grants to the applicants described in the notice. It expected to make one award. Applications closed on April 19, 2021.
From the official notice on Grants.gov, last changed March 25, 2021. Checked November 7, 2026.
- Expected awards1
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 18, 2021 |
|---|---|
| Deadline | April 19, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants that can apply for this NOFO are: Serviço de Saúde da Cidade de Maputo (Maputo City Health Services), Mozambique
Is this a realistic fit?
- Most of the program's money (62% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $350,000 for Year 1, subject to the availability of funds. This NOFO will focus on strengthening the institutional capacity of the Serviço de Saúde da Cidade de Maputo (SSC)/Maputo City Health to develop, plan, and coordinate the HIV program in Maputo City. This NOFO will also strengthen leadership oversight and coordination of PEPFAR HIV prevention, care, support, and treatment services in the city. Furthermore, this NOFO will promote collaboration among PEPFAR implementing partners and key stakeholders involved in HIV service delivery in Maputo City. This collaboration will to improve the service delivery models and strengthen the health system.
Who has won Global AIDS grants before
From fiscal 2021 to 2025, Global AIDS (93.067) awarded $7.6 billion across 521 grant awards, an average of $14.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 32 | $684 million |
| Elizabeth Glaser Pediatric AIDS Foundation | District of Columbia | 13 | $387 million |
| Management and Development for Health | 5 | $282 million | |
| Apin Public Health Initiatives LTD/Gte | 4 | $209 million | |
| University of Washington | Washington | 8 | $195 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH21-2156 still open?
No. It closed on April 19, 2021.
Who can apply for Maintaining and Strengthening Institutional Capacity of Maputo City Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Centers for Disease Control - CGH accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Maintaining and Strengthening Institutional Capacity of Maputo City Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Closed April 19, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won Global AIDS grants before?
The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)